跳至主要内容
临床试验/IRCT201204037202N5
IRCT201204037202N5已完成3 期

Comparing efficacy and side effects of Memantine and Risperidone in treating autistic patients

Tehran University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
4 years 至 17 years(—)
性别
All

入选标准

  • inclusion criteria: age of 4-17 year old; autistic patients not received any drug for treatment in past or not responded adequately to previous drugs; seizure attacks in epileptic patients should be controlled and any change in dose and kind of antiepileptic drugs should not be made from one month before entrance to the study.
  • exclusion criteria: any neurologic disease except for seizure; substance abuse; pregnancy; any history of neuroleptic malignant syndrom and history of allergic reactions to mementine or risperidone; history of cardiovascular diseases, malignant hematologic diseases, acute kidney or liver failure.

排除标准

  • 未提供

研究者

相似试验

Comparing efficacy and side effects of Memantine and... | 临床试验